1995
DOI: 10.1016/s0022-2828(08)80036-3
|View full text |Cite
|
Sign up to set email alerts
|

Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
126
0
2

Year Published

1999
1999
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 181 publications
(141 citation statements)
references
References 37 publications
7
126
0
2
Order By: Relevance
“…This hypothesis is further supported by 3 major findings: 1) the antoantibodies exert agonistic and apoptotic effects in cultured cardiomyocytes (1,(4)(5)(6), 2) immunization with a synthetic peptide corresponding to a sequence in the second extracellular loop of the human adrenergic receptor (β 1 -EC II ) produces cardiomyopathy in a number of experimental animals (7)(8)(9)(10), and 3) removal of anti-β 1 -EC II antibodies improves cardiac function in the rabbit β 1 -EC II cardiomyopathy (11), and human dilated cardiomyopathy (12). Furthermore, isogenic transfer of sera from rats immunized with the β 1 -EC II peptide to healthy littermates produces cardiac morphology similar to the cardiomyopathic changes in the donor rats (9).…”
Section: Introductionmentioning
confidence: 61%
“…This hypothesis is further supported by 3 major findings: 1) the antoantibodies exert agonistic and apoptotic effects in cultured cardiomyocytes (1,(4)(5)(6), 2) immunization with a synthetic peptide corresponding to a sequence in the second extracellular loop of the human adrenergic receptor (β 1 -EC II ) produces cardiomyopathy in a number of experimental animals (7)(8)(9)(10), and 3) removal of anti-β 1 -EC II antibodies improves cardiac function in the rabbit β 1 -EC II cardiomyopathy (11), and human dilated cardiomyopathy (12). Furthermore, isogenic transfer of sera from rats immunized with the β 1 -EC II peptide to healthy littermates produces cardiac morphology similar to the cardiomyopathic changes in the donor rats (9).…”
Section: Introductionmentioning
confidence: 61%
“…The pathogenic properties of desmin-mutation were shown in a mouse model for desminopathy as well; transgenic mice with a 7-amino acid deletion (D7-des) exhibited structural defects of the myocardium that resembled human desminrelated cardiomyopathy with aberrant intrasarcoplasmic and electron-dense granular filamentous aggregates that were desmin-positive [32]. Abnormalities of the humoral immune system are present in patients with DCM, and various antibodies have been identified in DCM [2][3][4][5][6][7]. Animal models further indicate that under certain pathological conditions, DCM can be triggered by autoantibodies.…”
Section: Discussionmentioning
confidence: 99%
“…Disturbances in humoral immunity play an important role in cardiac dysfunction of DCM patients. A number of autoantibodies against cardiac cell proteins have been identified in DCM: e.g., antibodies against the cardiac beta-1 adrenergic receptor, contractile proteins, mitochondrial proteins and the muscarinic acetylcholine receptor-2 [2][3][4][5][6][7]. Experimental and clinical data indicate that cardiac antibodies play an active role in the pathogenesis of DCM and may contribute to cardiac dysfunction.…”
Section: Introductionmentioning
confidence: 99%
“…Isolation, cultivation, and detection procedures have been described in detail previously. 13 The doseresponse relationship between activating IgG or angiotensin II concentration and the spontaneous beating rate is linear.…”
Section: Bioassays and Analysis Of Epitopesmentioning
confidence: 99%